Clinical trial · Observational
Urine Albumin/Creatinine Ratio and Renal Function Differences in Phenotypes of Polycystic Ovary Syndrome.
NCT07441811CI-TRIAL-00104368completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Since there are different metabolic effects in different phenotypes of polycystic ovary syndrome (PCOS); in this study; the investigators aimed to investigate whether there is a difference between glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (ACR) levels in different PCOS phenotypes and compare healthy controls.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glomerular Filtration Rate | — | UNRESOLVED | — |
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
| Urine Albumin \(UAlb\) | — | UNRESOLVED | — |
| Urine Creatinine \(UCr\) | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (5)
- label
- Controls
- description
- Healthy controls between 18-35 years.
- label
- PCOS Phenotype A
- description
- Hyperandrogenemia+oligoanovulation+PCO appearance on USG.
- label
- PCOS Phenotype B
- description
- Hyperandrogenemia+oligoanovulation
- label
- PCOS Phenotype C
- description
- Hyperandrogenemia+PCO appearance on USG.
- label
- PCOS Phenotype D
- description
- Oligoanovulation+PCO appearance on USG.
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 35 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients who applied for reasons such as hair growth, acne, menstrual irregularity or infertility and were diagnosed with PCOS after examination, biochemical, hormonal and sonographic tests, 2. Female patients between the ages of 18-35, 3. Patients without known cancer, liver or kidney failure, 4. Patients who do not take drugs, ACEIs and ARBs. 5. Female patients without active infection will be included. - Exclusion Criteria: 1. Female patients \<18 years of age and \>35 years of age, 2. Patients with known cancer, liver and kidney failure, 3. Patients taking drugs, ACEIs and ARBs, 4. Patients with active infection will not be included in the study. -
References
Publications (0)
Data not yet available
No reference posted for this study.